Atlas Venture Opportunity Fund I, L.P.

Insider Reports History

Entity
Company
Location
400 Technology Square, 10 Th Floor, Cambridge, MA
Signature
Atlas Venture Opportunity Fund I, L.P., By: Atlas Venture Associates Opportunity I, L.P., its general partner, By: Atlas Venture Associates Opportunity I, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Opportunity Fund I, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 1.46M $43.8M $30.05 Mar 1, 2024 Direct
Dyne Therapeutics, Inc. 10%+ Owner Common Stock 847K $25.5M $30.05 Mar 1, 2024 Indirect
Day One Biopharmaceuticals, Inc. 10%+ Owner Common Stock 793K $9.27M $11.69 Jul 1, 2022 Direct

Insider Reports Filed by Atlas Venture Opportunity Fund I, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DYN Dyne Therapeutics, Inc. Mar 1, 2024 2 -$1.4M 4 Mar 5, 2024 10%+ Owner
DAWN Day One Biopharmaceuticals, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 10%+ Owner